NCT07237204

Brief Summary

The goal of this clinical trial is to evaluate the safety of two durations of the Pringle maneuver in adults undergoing elective liver resection for malignant tumors. The main questions it aims to answer are: Is the incidence of post-hepatectomy liver failure different between 15-minute and 45-minute Pringle maneuver durations?

  • Do the durations differ in operative time or intraoperative blood loss?
  • Researchers will compare patients randomized 1:1 to 15 minutes vs 45 minutes of Pringle clamping to see if outcomes are non-inferior between groups. Participants will:
  • Undergo standard oncologic hepatectomy with the assigned Pringle duration.
  • Receive routine perioperative assessments, including laboratory tests and clinical evaluations.
  • Attend follow-up visits at approximately 6 months, 1 year, and 3 years after surgery.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
600

participants targeted

Target at P75+ for not_applicable

Timeline
55mo left

Started Dec 2025

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress9%
Dec 2025Nov 2030

First Submitted

Initial submission to the registry

November 14, 2025

Completed
5 days until next milestone

First Posted

Study publicly available on registry

November 19, 2025

Completed
12 days until next milestone

Study Start

First participant enrolled

December 1, 2025

Completed
2.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2028

Expected
2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2030

Last Updated

November 19, 2025

Status Verified

October 1, 2025

Enrollment Period

2.9 years

First QC Date

November 14, 2025

Last Update Submit

November 14, 2025

Conditions

Keywords

Pringle manouverLiver malignancyLiver resection

Outcome Measures

Primary Outcomes (1)

  • Posthepatectomy liver failure

    Posthepatectomy liver failure defined by the International Study Group of Liver Surgery as a postoperative deterioration of the liver's synthetic, excretory, and detoxifying functions, characterized by an increased INR and concomitant hyperbilirubinemia (per local lab normals) on or after postoperative day 5.

    On or after postoperative day 5

Secondary Outcomes (2)

  • Intraoperative blood loss

    At the completion of the surgery

  • Parenchymal transection time

    At the completion of the surgery

Study Arms (2)

15 minute Pringle manouver with 10 minute reperfusion

EXPERIMENTAL

Hepatic pedicle clamping for 15 minutes, followed by a 10-minute declamping period during liver transection.

Procedure: Pringle manouver

45 minute Pringle manouver with 15 minute reperfusion

EXPERIMENTAL

Hepatic pedicle clamping for 45 minutes, followed by a 15-minute declamping period during liver transection.

Procedure: Pringle manouver

Interventions

The Pringle maneuver involves temporary clamping of the hepatic pedicle during liver resection to reduce blood loss during parenchymal transection.

15 minute Pringle manouver with 10 minute reperfusion45 minute Pringle manouver with 15 minute reperfusion

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Diagnosis of a primary or secondary malignant liver tumor.
  • Age \> 18 years.
  • Patient deemed eligible for liver resection.
  • WHO performance status ≤ 2.
  • Ability to provide written informed consent.

You may not qualify if:

  • Liver cirrhosis.
  • Liver dysfunction classified as Child-Pugh class B or C.
  • Repeat hepatectomy.
  • Prior ablation or chemoembolization of hepatic lesions.
  • Prior portal vein branch embolization.
  • Planned or performed ALPPS procedure.
  • Concomitant resection of any organ other than the gallbladder during the same operation.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of General, Transplant and Liver Surgery, Medical University of Warsaw

Warsaw, 02-091, Poland

Location

Related Publications (6)

  • Wang HP, Hou TY, Li WF, Yong CC. Inflow control can be safely used in laparoscopic subsegmentectomy of the liver: a single-center 10-year experience. BMC Surg. 2023 Dec 6;23(1):366. doi: 10.1186/s12893-023-02282-2.

    PMID: 38057769BACKGROUND
  • van den Broek MA, Bloemen JG, Dello SA, van de Poll MC, Olde Damink SW, Dejong CH. Randomized controlled trial analyzing the effect of 15 or 30 min intermittent Pringle maneuver on hepatocellular damage during liver surgery. J Hepatol. 2011 Aug;55(2):337-45. doi: 10.1016/j.jhep.2010.11.024. Epub 2010 Dec 13.

    PMID: 21147188BACKGROUND
  • Doi S, Yasuda S, Hokuto D, Kamitani N, Matsuo Y, Sakata T, Nishiwada S, Nagai M, Nakamura K, Terai T, Kohara Y, Sho M. Impact of the Prolonged Intermittent Pringle Maneuver on Post-Hepatectomy Liver Failure: Comparison of Open and Laparoscopic Approaches. World J Surg. 2023 Dec;47(12):3328-3337. doi: 10.1007/s00268-023-07201-3. Epub 2023 Oct 3.

    PMID: 37787778BACKGROUND
  • Liu J, Wang W, Shi C, Li C, Xue F, Hu L, Wang Y, Ge R. The difference in prolonged continuous and intermittent Pringle maneuver during complex hepatectomy for hepatocellular carcinoma patients with chronic liver disease: A retrospective cohort study. Cancer Med. 2021 Dec;10(23):8507-8517. doi: 10.1002/cam4.4361. Epub 2021 Oct 18.

    PMID: 34658153BACKGROUND
  • Fagenson AM, Gleeson EM, Nabi F, Lau KN, Pitt HA. When does a Pringle Maneuver cause harm? HPB (Oxford). 2021 Apr;23(4):587-594. doi: 10.1016/j.hpb.2020.07.014. Epub 2020 Sep 12.

    PMID: 32933844BACKGROUND
  • Huang Y, Liao A, Pu X, Yang J, Lv T, Yan L, Yang J, Wu H, Jiang L. A randomized controlled trial of effect of 15- or 25-minute intermittent Pringle maneuver on hepatectomy for hepatocellular carcinoma. Surgery. 2022 Jun;171(6):1596-1604. doi: 10.1016/j.surg.2021.11.012. Epub 2021 Dec 13.

    PMID: 34916072BACKGROUND

MeSH Terms

Conditions

Carcinoma, Hepatocellular

Condition Hierarchy (Ancestors)

AdenocarcinomaCarcinomaNeoplasms, Glandular and EpithelialNeoplasms by Histologic TypeNeoplasmsLiver NeoplasmsDigestive System NeoplasmsNeoplasms by SiteDigestive System DiseasesLiver Diseases

Study Officials

  • Emilia Kruk, MD

    Medical University of Warsaw

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 14, 2025

First Posted

November 19, 2025

Study Start

December 1, 2025

Primary Completion (Estimated)

November 1, 2028

Study Completion (Estimated)

November 1, 2030

Last Updated

November 19, 2025

Record last verified: 2025-10

Data Sharing

IPD Sharing
Will not share

We do not plan to share individual participant data (IPD). The design of this study does not require public IPD sharing for the reliability of the published results. De-identified IPD may be provided to journal peer reviewers under confidentiality during manuscript review.

Locations